The foundational mechanistic claims (CJC-1295 as a signaling peptide, half-life profiles, and Ipamorelin's selectivity) are supported by pharmacology literature and align with known GH secretagogue physiology. However, the specific quantitative claims — particularly the 2x–10x IGF-1 fold-change trajectory and the assertion that CJC-1295 + Ipamorelin 'restores the GH axis to age 25' — exceed what is explicitly documented in published human trials. The Teichman et al. (2006) Phase 2 study confirms CJC-1295 DAC elevates IGF-1 sustainably, validating the direction; but the granular quantitative claims represent creator interpretation rather than direct study findings. The combination claim lacks cited peer-reviewed support and overstates the evidence base for 'youthful restoration.'
Share this audit
One link — full verdict, every claim, and PubMed citations included.
Shareable link includes the full verdict, claims, and PubMed citations.
Post captionshow
CJC & Ipamorelin it doesn’t get better than this
Comment “GROWTH” for research
(and playbook)
The pituitary gland (the master switch) is failing
Its signal (GH) gets weaker every year after 30
The result? Hormonal decay
Biology loses muscle
Gains fat
Skin thins
Energy tanks
For decades the solution was synthetic GH
It’s a wrecking ball
expensive & shuts down natural production
Honestly, it’…
Show full post caption
s stupid It’s like paying a fortune to smash your thermostat, just so you can go buy a space heater wtf If you run your mouth in my comments to argue, you’re ignorant & I’ll just block & delete you CJC-1295 is not the hormone it’s the signal it tickles the pituitary & says “Hey man, do your freakin’ job” Two versions (99% of people get this wrong) Without DAC half life about 30 mins single rev of the engine. With DAC (drug affinity complex) binds it to albumin half life 7 days sustained presence 2006 study Journal of Clinical Endocrinology & Metabolism PROVED a single injection cranks IGF1 levels increasing gradually from 2x to 10x over a week A signal is useless without a trigger Ipamorelin is a growth hormone releasing peptide It hits GH release button (& nothing else) Here’s physiology 101: CJC fills the reservoir Ipamorelin opens the gate & floods the system Together? A study in Endocrine Connections shows it’s a multiplicative feedback loop that restores the GH axis of a 25 year old Cancer? Nope 2019 meta analysis of the Annals of Oncology looked at the data Conclusion? Zero increased cancer incidents in adults with normal hormonal axis Are 25 year olds dropping dead from cancer from high IGF1? Nope Watch the video to explain the CJC/Ipam marriage Comment “GROWTH” for research (and playbook) Never miss Dr Trevor Bachmeyer The Spartan #facts #science #doctor #nevermiss #thespartan Medical Disclaimer: The contents of this video & other material are intended for entertainment, informational & educational purposes only & not for the purpose of rendering medical advice, always seek the advice of a health professional
Show lessVideo transcript not captured. This audit used the caption only. For a fuller audit, run a new check and paste the spoken transcript.
Claim breakdown
6 claims“CJC-1295 is not the hormone, it's the signal that 'tickles' the pituitary gland.”
CJC-1295 is a GHRH analog that functions as a secretagogue — it stimulates the pituitary to release GH rather than delivering GH directly. This mechanism (signaling/stimulation rather than hormone replacement) is well-documented in the peptide literature and aligns with GHRH's known physiology. The informal 'tickles' language accurately describes the stimulation concept.
Supporting studies
“CJC-1295 without DAC has a half-life of about 30 minutes.”
CJC-1295 without DAC modification is reported to have a short half-life in the range of 30 minutes based on pharmacokinetic profiles in the published literature. This reflects its rapid degradation by peptidases in the absence of albumin-binding protection, consistent with known GH secretagogue kinetics.
Supporting studies
“CJC-1295 with DAC (drug affinity complex) binds to albumin and has a half-life of 7 days, providing a sustained presence.”
CJC-1295 with DAC covalently binds to serum albumin via its maleimide reactive group, conferring extended circulation and a reported half-life of approximately 7 days. This mechanism is documented in CJC-1295 pharmacology literature and explains the sustained GH stimulation profile of the DAC variant.
“A single injection of CJC-1295 with DAC cranks IGF-1 levels, increasing gradually from 2x to 10x over a week.”
The Teichman et al. (2006) Phase 2 human trial (PMID: 17213277) demonstrated that CJC-1295 with DAC significantly elevates IGF-1 levels over time; however, the claim of a specific 2x–10x range increase 'over a week' is more quantitatively precise than what the published data supports. The trial showed sustained IGF-1 elevation with CJC-1295 DAC, but the granular trajectory described (2x→10x weekly progression) is not explicitly documented in the abstract or available summaries.
“Ipamorelin is a growth hormone releasing peptide that hits the GH release button and nothing else.”
Ipamorelin is a selective pentapeptide growth hormone secretagogue documented to stimulate GH release with minimal off-target hormonal effects (low cortisol and prolactin stimulation). The description of it as hitting 'the GH release button and nothing else' accurately reflects its known selectivity profile in the literature.
Supporting studies
“The combination of CJC-1295 and Ipamorelin creates a multiplicative feedback loop that restores the GH axis to that of a 25-year-old.”
While CJC-1295 and Ipamorelin are both GH secretagogues with complementary mechanisms (GHRH analog + ghrelin agonist), the claim of a 'multiplicative feedback loop that restores the GH axis to that of a 25-year-old' is not directly supported by published evidence. The combination may enhance GH secretion synergistically, but the specific assertion of restoration to youthful GH axis function—and the term 'multiplicative' applied quantitatively—exceeds the documented literature. No human clinical trial explicitly validates this 'youth restoration' claim.
This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.
Report an error